Introduction
Diabetes Mellitus (DM) is a metabolic illness that is defined by insufficient insulin production and/or impaired insulin use within the body. Diagnosis of DM involves the observation of a notable elevation in blood glucose levels (Azis et al., 2020). The global prevalence of diabetes mellitus (DM) has exhibited a consistent upward trend across diverse nations, encompassing both high-income, low-income, and middle-income countries. According to data collected by the World Health Organization (WHO) since 1980, there has been a fourfold increase in the global population of people diagnosed with diabetes mellitus (DM), reaching a staggering 422 million individuals. According to the World Health Organization (2016), diabetes was responsible for around 1.5 million deaths out of a total of 89 million mortalities in the year 2012. According to the findings of the Sample Registration Survey conducted in 2014, it is evident that diabetes mellitus (DM) ranks as the third leading cause of mortality in Indonesia, accounting for 6.7% of deaths. This places DM behind stroke, which accounts for 21.1% of deaths, and coronary heart disease, responsible for 12.9% of deaths. According to Riska (2016), the International Diabetes Federation reported an estimated population of 10 million individuals diagnosed with diabetes mellitus in Indonesia in 2015. If this pattern persists, it may have adverse consequences for the human population, such as reduced productivity, disability, and early mortality.
Diabetes mellitus (DM) has the potential to give rise to numerous problems, hence elevating the likelihood of macrovascular and microvascular abnormalities in multiple organs, including the heart, kidneys, eyes, and brain.
Disorders of the metabolism of carbohydrates may give rise to DM. a-glucosidase is the principal enzyme involved in the metabolism of carbohydrates. At the periphery of small intestinal cells, this enzyme facilitates the hydrolysis of complex oligosaccharides into monosaccharides or glucose, which are subsequently absorbed into the bloodstream (Chatsumpun, et al, 2017). Despite ongoing advancements in the scientific understanding of the biology of diabetes, current therapeutic interventions mostly focus on antihyperglycemic effects and do not effectively mitigate the development of diabetes-related comorbidities. A therapeutic strategy for managing diabetes mellitus involves the use of measures to impede the uptake of glucose into the bloodstream, namely by the inhibition of a-glucosidase enzyme activity (Garber, et al, 2013). Inhibition of this enzyme will have an impact on delaying glucose absorption (Khatri and Juvekar, 2014). Therefore, it is imperative to investigate potential innovative antidiabetic compounds to improve the overall well-being of individuals with diabetes in the future. Numerous individuals suffering from chronic illnesses, including diabetes patients, hold the belief that herbal medications might serve as a complementary form of therapy to enhance their overall well-being. This underscores the need for additional investigation into the potential benefits of this therapeutic approach for such patients (Ghorbani, 2017).
In a study conducted by Indra in 2019, it was found that the ethanol extract derived from the leaves of the Glochidion arborescens (Müll. Arg.) Boerl. plant shown promising qualities as a natural antioxidant. The extract demonstrated a total polyphenol content of 33.32 mg QE/g and a flavonoid content of 3.02 mg QE/g. The free radical reduction test results, specifically the DPPH assay, indicated an IC50 value of 5.62 µg/mL. This value was found to be higher than that of vitamin C, which exhibited an IC50 value of 3.34 µg/mL. Furthermore, it has been demonstrated that the ethanol extract derived from the leaves of the Mareme plant exhibits significant antioxidant properties. Mareme fraction leaves also have activity that could inhibit an active a-amylase enzyme inhibitory activity with an IC50 value of 28.262 ppm (Ambarsari and Haryoto, 2022).
According to Rostiani (2019), the concentration of 1.60 ppm aligns with the findings of antidiabetic experiments conducted on male mice. These experiments demonstrated a significant reduction in blood glucose levels by 72.2% following seven days of supplementation. According to Li et al. (2019), the potential antidiabetic benefits of flavonoid compounds can be attributed to their ability to enhance insulin production, modulate enzymes involved in glucose metabolism, improve insulin sensitivity, and facilitate glucose absorption by skeletal muscle and adipose tissue.
The plant often referred to as Sala, scientifically known as Cynometra ramiflora Linn, is frequently employed as a medicinal remedy for many ailments such as gout, diabetes, hypertension, and other medical conditions inside the Kraton Kasunanan Surakarta. The Sala plant is considered to be a plant species that is quite uncommon. Therefore, there is a limited body of research on this substance's pharmacological actions and chemical ingredients. The water extract (godogan) derived from the leaves and stems of the Sala plant is purported to possess curative properties for various ailments, based on empirical evidence.
The medical conditions encompassed in this list consist of hypertension, diabetes, gout, and hypercholesterolemia. Prior research has indicated that Cynometra ramiflora Linn plants originating from several nations had promising qualities as antidiabetic agents, antimicrobial agents (Khan et al., 2006), and antioxidants (Bunyapraphatsara et al., 2003) cytotoxic and in vivo biological activity (Sabiha et al, 2022), also antiviral activity (Meutia and Dewi, 2017; Yusuf et al., 2018). Consequently, it is imperative to examine the chemical composition, pharmacological properties, potential toxicity, and appropriate formulations of this plant to establish standardized herbal medications, thereby establishing a robust scientific basis (Haryoto et al., 2013). This study aimed to investigate the potential antidiabetic properties of the ethanol extract derived from the leaves of the Mareme plant (Glochidion arborescens (Müll. Arg.) Boerl.). The inhibitory activity of the leaves of the Cynometra ramiflora Linn plant against the a-glucosidase enzyme was assessed in vitro. Additionally, chemical ingredients were identified by the utilization of phytochemical screening methods.